Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa2g00277 ATGTTTGTCTCTCTTTATTTCACTCAACTCAAATCTCTTTGGGATGAACTCAATTCTATTGCTCATGTCAATCCTTGTATATATGATAATGCTAAAAGTATTCTTGATCAGCATAATCAAGATCGTGCCATGGAATTCCTTCAAGGAGGTCATGACCGTTTTTCAGCTGTCGACATGATTTCGATTCAGTTTCTTGATTCAGATTTCGAAACCAGGATGGAAGCCCTTGCTGTTACAGTCTTGGAAAAGTTGGGCTCTTCAGTTTACAAAGAGCTTGGAATCATTTGGAATCTAGAAGAGGATATGGAAAAAATGAAGACCACAGTATCTATGATAAAATCAGTACTCCTGGATGCAGAGACCAAGGCCAATAATCATCAAGTTAGTAATTGGTTGGAGGAGCTGAAAGATGTACTTTATGATGCAGATGATTTACTAGATGATTTTTCCATTGAAGATTTGAAAGGAAAAGCGATGGCTAGAAACAAAAAAGTAAAACAGGTACTATGTTTCTTCTCAAAACCAAACAAAATTGCCTATAGTTATACATTAGGCCGTCGAATGAAAGCAATCCAGAAGAGGCTAGATGACATTGCTAAAAATAAGCATGCGCTGCAACTAACTGACCGCCCTATGGAGAATCCAATTGTATATAGGGAACAAAGACAAACTTACTCTTTTGTGAGTAAAAATGAAGTTATTGGAAGAGAAGATGAAAAGAAACGTATAAAGCGTTATCTACTTGATATCAATGCTTCAGATAATGTTTCTGTAATTCCTATAGTTGGGATTGGAGGATTAGGTAAGACCGCACTTGCTCAACTAGTCTACAATGATAATGATGTTCAAAGGCATTTTGAGCTAAAAATGTGGGTGTATGTTTCTGATGAATTTGATATAAAGAAAATAGCTCGGGAGAGCATCGGGGATGAAAAGAATAGTCTGATGGAGCAAGTTCAACAGCAACTTAGAGACAAAATTCGAGGGAAAAAGTTTTTGCTTGTGTTAGATGACATATGGAACGAGGATCGTGAACTGTGGCTTAAGTTGAAGAGCTTGTTCATGGAAGGAGGAAAAGGAAGCATGGTAATTGTTACAACGCGTAGTCAGACTGTGGCGAAAATAGCAGGCACACATCCGCCTCTTTTCTTAGAAGGTTTGGATTCACAAAAATCACAGGAGTTATTCTCTCGAGTGGCTTTCGGGGAGTCAAAAGAGCAAAATGATTTGGAATTGTTAGCTATAGGAAGGGACATTGTTAAAAAATGTGCTGGCATCCCTCTTGCTATAAGGACTATTGGAAGCCTTTTGTTTTCTCGAAATTTGGGCAGAAGTGATTGGCTATATTTCAAGGATGTTGAGTTTTCAAAGATAGATCAACACAATGACAAAATCTTTTCAATCCTTAGACTGAGTTATGATCATCTTCCCTCATTTCTAAAAAAATGTTTTGCTTATTGTTCATTGTTTCCTAAAGGTTTTGTGTTTGAAAAGAAGACTCTCATTCATTTATGGGTAGCTGAGGGGTTCATTCAACAATCAAATGATATTAGATGCGTAGAAGATGTTGGTCAAGAGTACTTCATGAGTTTGCTGTCAATGTCCTTCTTTCAAGATGTCACTATGGACGATTGTGGTGGCGTAAGTACTTGTAAAATGCATGACCTTATGCATGATCTGGCACAGCTAATAGTCGGGAATGAATATGCGGTGTCTGAAGGAGAAGAAGCAAACATTGTAAACCGAACGCGTTATTTGTCTTCTCGTACTGCATTACAGTTCGGACCACCATCGCCATCTTCCTACAAGTTAAGGACATTTCATTTACTTCCACAAGTGAATTCAAGCAATCATTTGCGCCAGACACATGTTCTTTCCTTTTCAGGCCTAAAGTTCTTACGCGTGTTGACACTTTGTGGGTTGCATATTGTTGCAATCCCAAATAGTATTGGAGAGATGAAGCATTTAAGATACATTGATCTATCAAAGAATATTGCACTTAAAGATCTTCCGCCGGGAATTACTAGCCTGCAGAGCTTGCAAACTCTAAAACTTTCTGAATGTTCTGAGCTCGAAATTTTACCAAAATATCTCAATAAAAGTCTCAGGCATATTGAGTTGAATGGTTGTGTGAAGTTGACATGTATGCCACAAGGGTTAGGACAGTTGACCAATCTTCAAACACTAACACTTTTTGTATGTGGCAAAGGAAGTACAGGTGTTAACGAGCTGCGTGACCTAAACAACCTTAGAGGGAGATTAGAAATCAAAGGGTTGGATTCACTTCAAATTAGTGCTGCAGAGATTGAATATGCAAAAGTACTTATTGAGAAGCAACACCTTCAACAATTGGAATTGCGGTGGACGTACCATATTACTTTCAATCTGTGGTCATCACTGCCCGTAAGGGACGAGTTATGGTTGGAAGATGAGATGGTTTTAGAAGCTTTGCAGCCACACCACTCACTTCAAAAGCTTGTTATAGATGGATTTTGGGGCAAAAAGTTACCGGACTGGATAGGGACTCTCTCGTCTCTCTTGACTATTGAGATCCACAATTGCAATGGTTTGACATCACTACCTGAAGCAATGTGTAACCTTGTATCGTTGCAGAAACTTTGCATATATAACTGCCAACAATTGAGTGAAATTTATGCAAAACCATACGGAAAAGAATGGCCGAAAATTTCTCACATTCGAGAAGTTGAGATCCTTCCTCTGAGTCCATCATTACTCAAGTACTTCAGTTGA 2751 0.3846 MFVSLYFTQLKSLWDELNSIAHVNPCIYDNAKSILDQHNQDRAMEFLQGGHDRFSAVDMISIQFLDSDFETRMEALAVTVLEKLGSSVYKELGIIWNLEEDMEKMKTTVSMIKSVLLDAETKANNHQVSNWLEELKDVLYDADDLLDDFSIEDLKGKAMARNKKVKQVLCFFSKPNKIAYSYTLGRRMKAIQKRLDDIAKNKHALQLTDRPMENPIVYREQRQTYSFVSKNEVIGREDEKKRIKRYLLDINASDNVSVIPIVGIGGLGKTALAQLVYNDNDVQRHFELKMWVYVSDEFDIKKIARESIGDEKNSLMEQVQQQLRDKIRGKKFLLVLDDIWNEDRELWLKLKSLFMEGGKGSMVIVTTRSQTVAKIAGTHPPLFLEGLDSQKSQELFSRVAFGESKEQNDLELLAIGRDIVKKCAGIPLAIRTIGSLLFSRNLGRSDWLYFKDVEFSKIDQHNDKIFSILRLSYDHLPSFLKKCFAYCSLFPKGFVFEKKTLIHLWVAEGFIQQSNDIRCVEDVGQEYFMSLLSMSFFQDVTMDDCGGVSTCKMHDLMHDLAQLIVGNEYAVSEGEEANIVNRTRYLSSRTALQFGPPSPSSYKLRTFHLLPQVNSSNHLRQTHVLSFSGLKFLRVLTLCGLHIVAIPNSIGEMKHLRYIDLSKNIALKDLPPGITSLQSLQTLKLSECSELEILPKYLNKSLRHIELNGCVKLTCMPQGLGQLTNLQTLTLFVCGKGSTGVNELRDLNNLRGRLEIKGLDSLQISAAEIEYAKVLIEKQHLQQLELRWTYHITFNLWSSLPVRDELWLEDEMVLEALQPHHSLQKLVIDGFWGKKLPDWIGTLSSLLTIEIHNCNGLTSLPEAMCNLVSLQKLCIYNCQQLSEIYAKPYGKEWPKISHIREVEILPLSPSLLKYFS 916
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vifa2g00277 916 PRINTS Disease resistance protein signature 258 273 - -
Vifa2g00277 916 PRINTS Disease resistance protein signature 423 437 - -
Vifa2g00277 916 PRINTS Disease resistance protein signature 326 340 - -
Vifa2g00277 916 PRINTS Disease resistance protein signature 675 691 - -
Vifa2g00277 916 Gene3D - 386 472 IPR042197 -
Vifa2g00277 916 Pfam NB-ARC domain 237 474 IPR002182 GO:0043531
Vifa2g00277 916 Gene3D - 78 186 - -
Vifa2g00277 916 Pfam Rx N-terminal domain 79 164 IPR041118 -
Vifa2g00277 916 SUPERFAMILY L domain-like 552 884 - -
Vifa2g00277 916 FunFam Probable disease resistance protein At1g61300 217 381 - -
Vifa2g00277 916 Gene3D - 217 379 IPR027417 -
Vifa2g00277 916 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 215 487 IPR027417 -
Vifa2g00277 916 Gene3D - 473 563 IPR036388 -
Vifa2g00277 916 FunFam Probable disease resistance protein At1g63360 473 563 - -
Vifa2g00277 916 Gene3D Ribonuclease Inhibitor 601 913 IPR032675 -
Vifa2g00277 916 PANTHER DISEASE RESISTANCE PROTEIN RP 104 875 IPR044974 GO:0006952
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vifa2g00277 Vifa-Chr2 43555535 43563689 Tandem
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa2g00277 240 916 WRKY Transcription Factor Family AT5G45050 23.297 9.60e-13 70.5
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa2g00277 - - mtr:11424880 1098.57